SCHEMBL4393416

SCHEMBL4393416

CCC#CCOc1nsc(C2CCCC2)n1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4385877 0.99 HCAR2 (0.31) HCAR2
SCHEMBL4396372 0.89
SCHEMBL4393840 0.87
SCHEMBL4388128 0.87 ADAM17 (0.32)
SCHEMBL4391857 0.86 HCAR2 (0.32) HCAR2
SCHEMBL4389249 0.86 ADAM17 (0.32)
SCHEMBL4391843 0.84
SCHEMBL14393960 0.79 CYP1A2 (0.33)
SCHEMBL13591008 0.78 CYP1A2 (0.32)
SCHEMBL4390222 0.77 HCAR2 (0.34) HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569922-B1 1,2,4-THIADIAZOLE COMPOUNDS AND ARTHROPOD CONTROLLING COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL CO (JP) 2009-12-02 EP disclosed
EP-1569922-B1 1,2,4-THIADIAZOLE COMPOUNDS AND ARTHROPOD CONTROLLING COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL CO (JP) 2009-12-02 EP disclosed
US-7301032-B2 1,2,4-thiadiazole compounds and arthropod controlling composition containing the same SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2007-11-27 US disclosed
US-7301032-B2 1,2,4-thiadiazole compounds and arthropod controlling composition containing the same SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2007-11-27 US disclosed
US-20060052422-A1 1,2,4-Thiadiazole compounds and arthropod controlling composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060052422-A1 1,2,4-Thiadiazole compounds and arthropod controlling composition containing the same NAT1, C1S, C1R HCAR2 3274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.